Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
Go back to Viridian Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates| (NASDAQ: VRDN) | Delayed: 17.32 +0.04 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.28 | 52 Week High | $ | |||
| Open | $17.50 | 52 Week Low | $ | |||
| Day High | $17.78 | P/E | N/A | |||
| Day Low | $17.16 | EPS | $ | |||
| Volume | 1,269,031 | |||||

